Gene: KDM1B
Official Full Name: lysine demethylase 1Bprovided by HGNC
Gene Summary: Flavin-dependent histone demethylases, such as KDM1B, regulate histone lysine methylation, an epigenetic mark that regulates gene expression and chromatin function (Karytinos et al., 2009 [PubMed 19407342]).[supplied by OMIM, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05410 | KDM1B Knockout cell line (HeLa) | Human | KDM1B | 1:3~1:6 | Negative | Online Inquiry |
KO05411 | KDM1B Knockout cell line (HCT 116) | Human | KDM1B | 1:2~1:4 | Negative | Online Inquiry |
KO05412 | KDM1B Knockout cell line (HEK293) | Human | KDM1B | 1:3~1:6 | Negative | Online Inquiry |
KO05413 | KDM1B Knockout cell line (A549) | Human | KDM1B | 1:3~1:4 | Negative | Online Inquiry |
KDM1B Gene Knockout Cell Lines are specially engineered cell lines that have been genetically modified to remove the KDM1B gene, which encodes a lysine-specific demethylase involved in the regulation of gene expression through histone modification. These knockout cell lines serve as valuable tools in elucidating the role of KDM1B in various biological processes, including stem cell maintenance, differentiation, and tumorigenesis. By creating a targeted disruption of the KDM1B gene, researchers can study its specific contributions to cellular signaling pathways and the epigenetic landscape of different cell types.
The key mechanism of these cell lines lies in the disruption of the histone demethylation function attributed to KDM1B, which may influence chromatin structure and gene activation states. As a result, the KDM1B knockout cells provide insights into how the absence of this enzyme affects cellular behaviors and identity, making them crucial for understanding developmental biology and cancer research.
From a scientific perspective, KDM1B Gene Knockout Cell Lines have important applications in academia and clinical research, particularly in studies focusing on embryonic stem cells and various cancer types. They allow for the examination of whether KDM1B contributes to aberrant gene regulation, potentially leading to the identification of novel therapeutic targets for cancer treatment or regenerative medicine.
Compared to other gene knockout models, the KDM1B cell lines stand out due to their specificity and reproducibility. They offer a unique advantage by providing researchers with a reliable system to dissect the intricate roles of KDM1B in gene regulation without the confounding effects seen in non-specific knockouts. Additionally, these cell lines are readily accessible and can be easily incorporated into existing experimental frameworks.
For researchers and clinicians keen on advancing their understanding of cancer biology and epigenetics, KDM1B Gene Knockout Cell Lines represent an essential resource that can propel discoveries and enhance therapeutic strategies. Our company, with its extensive expertise in producing high-quality biological products, is committed to providing cutting-edge tools that empower the scientific community in their quest for knowledge and innovative solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.